From the CEO's AGM Presentation (page 6) - Delivery against 2018 Objectives:
_________
DX1 – TNBC brain metastases animal data
Q4 2018
DX1 – Additional solid cancer (TBC) animal data
Q1 2019
DX1 + radiation – brain cancer animal data
Q4 2018/Q1 2019
_________
From the CEO's AGM Presentation (Page 22) - Looking Ahead:
_________
DX1 + radiation – brain cancer animal data
Q4 2018/Q1 2019
DX1 – solid cancer (TBC) animal data
Q1 2019
DX1 + temazolamide – brain cancer animal data
Q1 2019
________
Comment: A couple of differences there. A far cry from the mid year and more straightforward
Aug 2018 - Solid cancer animal data
Oct 2018 - Additional solid cancer animal data
(neither of which materialised).
Also, wonder what happened to the provision of 'more complete pharmacokinetic profiling' (ann of 05-07-2018).
Sometimes silence is not golden. Easy to conclude things are not going exactly to plan.
- Forums
- ASX - By Stock
- PAB
- Ann: Chairman's Address and CEO Presentation to 2018 AGM
Ann: Chairman's Address and CEO Presentation to 2018 AGM, page-51
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.7¢ | $18.65K | 2.665M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 80873 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 1638632 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 80873 | 0.007 |
15 | 3605686 | 0.006 |
9 | 3659992 | 0.005 |
5 | 4174000 | 0.004 |
4 | 2729016 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 1638632 | 8 |
0.009 | 108695 | 1 |
0.010 | 1806000 | 4 |
0.011 | 1600000 | 3 |
0.012 | 292407 | 2 |
Last trade - 15.31pm 27/06/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |